Oneness Biotech sent out internal questionnaires to the department in charge who had its colleagues fill out the questionnaire based on the stakeholder’s issues of concern for the company in the past. The degree of concern is divided into 5 levels, with 5 representing the highest and 1 representing the lowest degree of concern. An average score was then derived from the degree of concern for each sustainability issue. At the same time, online questionnaires were distributed to the senior supervisors so that they are able to score the degree of impact the sustainability issues had on the company in terms of economic, environmental, and social aspects. The degree of impact is divided into 5 levels, with 5 representing the highest and 1 representing the lowest degree of impact. An average score was then derived from the degree of impact for each sustainability issue. The two scores were then introduced to the “Matrix of Material Topics” so that the 5 material topics of the year were identified as the key points:
- Business performance
- Legal compliance
- Drug safety
- ntellectual property rights protection
- Cyber securityprotection
The three main axes of Oneness Biotech ESG are summarized as follows:
- continue to make profits under legal compliance
- join efforts with advanced biotechnology and talents to develop new drugs for the benefit of mankind
- strengthen cyber security to ensure R&D advantages
In order to find the balance for the disclosure of the ESG report, we additionally chose to disclose water resources & wastewater management, occupational safety & health, energy conservation & carbon reduction, and waste management as supplementary topics.
Due to different material topics, the boundaries (scopes) of possible impacts are also different. Oneness Biotech identifies the boundaries of material topics as follows:
